Ziresovir reduces respiratory syncytial virus (RSV) symptoms and viral load in infants, offering hope for an effective ...

For infants and young children hospitalized with respiratory syncytial virus (RSV) infection, ziresovir reduces signs and ...

Results of a phase 2 trial suggested that ziresovir may have efficacy in the treatment of infants hospitalized with RSV infection. In a phase 3, multicenter, double-blind, randomized, placebo ...

The researchers found that treatment with Ziresovir, an antiviral medication, significantly alleviated the signs and symptoms ...

Shanghai Ark Biopharmaceutical Co., Ltd. ("ArkBio"), a clinical stage biopharmaceutical company focused on the development of ...

Current strategies to prevent severe RSV disease in infants include maternal vaccination with the RSV prefusion F vaccine ...